Nuvation Bio annual operating margin
2024
2025
Nuvation Bio's operating margin was −338.72% for fiscal 2025.
View full Nuvation Bio company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −338.72% | +7188.61 pp |
| 2024 | 2024-12-31 | −7,527.33% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −161.06% | +1154.66 pp |
| Q1 2026 | 2026-03-31 | 4.66% | +1917.89 pp |
| Q4 2025 | 2025-12-31 | −81.30% | +863.23 pp |
| Q3 2025 | 2025-09-30 | −430.14% | +6186.23 pp |
| Q2 2025 | 2025-06-30 | −1,315.73% | +31463.72 pp |
| Q1 2025 | 2025-03-31 | −1,913.23% | — |
| Q4 2024 | 2024-12-31 | −944.53% | — |
| Q3 2024 | 2024-09-30 | −6,616.37% | — |
| Q2 2024 | 2024-06-30 | −32,779.44% | — |
Across the available reported history, Nuvation Bio's operating margin increased from −7,527.33% to −338.72%, a change of +7188.61 percentage points. The latest reported quarter, Q2 2026, shows −161.06%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nuvation Bio filings at SEC.gov ↗